DE:ANW Stock Latest News
Company AnnouncementsImmuron CEO to showcase infectious-disease portfolio at Emerging Growth Conference4d ago
Company AnnouncementsImmuron trims ATM facility to US$2 million while preserving funding flexibility5d ago
Company AnnouncementsImmuron lifts Q1 sales on Travelan surge despite U.S. softness5d ago
Company AnnouncementsImmuron CEO to Spotlight Oral Antibody Platform at Emerging Growth Conference1w ago
Company AnnouncementsImmuron advances Travelan after Phase 2 data published in Nature journal2w ago
Company AnnouncementsImmuron Showcases Oral Antibody Platform at Coffee Microcaps Conference1M ago
The FlyImmuron to launch Proibs in the U.S.1M agoIMRN
Company AnnouncementsImmuron to Launch Calmino’s Digestive Health Device PROIBS in U.S. Market1M ago
Company AnnouncementsImmuron Issues FY26 Preliminary Results With Safe Harbor Caution2M ago
Company AnnouncementsImmuron Narrows Loss as Travelan Sales Lift Revenue and Cash Reserves2M agoCompany AnnouncementsImmuron CEO to Spotlight Oral Immunotherapy Portfolio at Emerging Growth Conference2M ago
Company AnnouncementsImmuron CEO Showcases Gut-Targeted Antibody Platform at TechKnow Invest Roadshow3M ago
- Company AnnouncementsImmuron Seeks Transformational Partnership for C. difficile Drug IMM-5293M ago
- Company AnnouncementsImmuron Adjusts Capital Structure as Over 3.8 Million Shares Cease4M ago
- Company AnnouncementsImmuron Options Lapse, Trimming Potential Dilution in Capital Structure4M ago
- Company AnnouncementsImmuron Says No Undisclosed News Behind Share Price Spike5M ago
Company AnnouncementsImmuron CEO to Spotlight Antibody-Based GI Portfolio at Emerging Growth Conference6M ago
